Last reviewed · How we verify
Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate for "TRUE Test® Panel 3" - a Phase II, Dose-Response Study.
It is the purpose of this study to determine the concentration of 3 allergens (goldnatriumthiosulphate, methyldibromoglutharonitrile \[MDBGN\], parthenolide) for diagnosing allergic contact dermatitis.
Details
| Lead sponsor | Mekos Laboratories AS |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 60 |
| Start date | 2005-04 |
| Completion | 2005-12 |
Conditions
- Allergic Contact Dermatitis
Interventions
- Goldnatriomthiosulphate, MDBGN, parthenolide
Primary outcomes
- Skin reaction from the 3 patch tests. (Allergic or irritant reaction, grade)
Countries
Denmark